HBK Investments L P increased its position in shares of AmerisourceBergen Corp. (NYSE:ABC) by 136.2% during the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund owned 86,600 shares of the company’s stock after buying an additional 49,941 shares during the period. HBK Investments L P’s holdings in AmerisourceBergen were worth $7,952,000 as of its most recent filing with the Securities and Exchange Commission.
Other institutional investors and hedge funds have also recently modified their holdings of the company. Addenda Capital Inc. acquired a new position in AmerisourceBergen during the fourth quarter worth $4,599,000. MML Investors Services LLC increased its holdings in AmerisourceBergen by 75.7% during the fourth quarter. MML Investors Services LLC now owns 20,999 shares of the company’s stock worth $1,928,000 after buying an additional 9,045 shares during the last quarter. JPMorgan Chase & Co. increased its holdings in AmerisourceBergen by 107.3% during the third quarter. JPMorgan Chase & Co. now owns 5,363,429 shares of the company’s stock worth $434,385,000 after buying an additional 2,776,287 shares during the last quarter. Baupost Group LLC MA acquired a new position in AmerisourceBergen during the third quarter worth $15,627,000. Finally, Highland Capital Management LLC acquired a new position in AmerisourceBergen during the fourth quarter worth $637,000. Institutional investors and hedge funds own 67.33% of the company’s stock.
A number of equities analysts recently weighed in on the stock. Mizuho set a $100.00 target price on shares of AmerisourceBergen and gave the stock a “hold” rating in a report on Wednesday, January 24th. Needham & Company LLC boosted their target price on shares of AmerisourceBergen from $86.00 to $88.00 and gave the stock a “buy” rating in a report on Wednesday, November 22nd. Zacks Investment Research upgraded shares of AmerisourceBergen from a “hold” rating to a “buy” rating and set a $103.00 target price on the stock in a report on Thursday, February 8th. Cowen restated a “buy” rating and set a $108.00 target price on shares of AmerisourceBergen in a report on Tuesday, February 27th. Finally, Leerink Swann set a $105.00 target price on shares of AmerisourceBergen and gave the stock a “buy” rating in a report on Tuesday, January 2nd. One analyst has rated the stock with a sell rating, six have given a hold rating, twelve have assigned a buy rating and one has issued a strong buy rating to the company’s stock. The company has a consensus rating of “Buy” and a consensus target price of $103.34.
In other news, CFO Tim G. Guttman sold 11,600 shares of the business’s stock in a transaction dated Wednesday, January 3rd. The shares were sold at an average price of $93.40, for a total value of $1,083,440.00. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, EVP Robert P. Mauch sold 3,000 shares of the business’s stock in a transaction dated Thursday, December 14th. The shares were sold at an average price of $90.00, for a total transaction of $270,000.00. Following the completion of the sale, the executive vice president now directly owns 14,531 shares of the company’s stock, valued at approximately $1,307,790. The disclosure for this sale can be found here. In the last three months, insiders sold 177,609 shares of company stock valued at $16,855,249. 27.30% of the stock is currently owned by company insiders.
AmerisourceBergen Corp. (NYSE:ABC) opened at $100.60 on Wednesday. The company has a current ratio of 0.95, a quick ratio of 0.50 and a debt-to-equity ratio of 1.61. AmerisourceBergen Corp. has a 52-week low of $71.90 and a 52-week high of $106.27. The company has a market cap of $22,030.61, a price-to-earnings ratio of 16.50, a price-to-earnings-growth ratio of 1.50 and a beta of 1.03.
AmerisourceBergen (NYSE:ABC) last announced its earnings results on Tuesday, February 6th. The company reported $1.55 earnings per share (EPS) for the quarter, beating the Zacks’ consensus estimate of $1.35 by $0.20. The company had revenue of $40.47 billion during the quarter, compared to analysts’ expectations of $40.42 billion. AmerisourceBergen had a net margin of 0.66% and a return on equity of 53.65%. AmerisourceBergen’s quarterly revenue was up 6.0% on a year-over-year basis. During the same quarter in the previous year, the business posted $1.36 earnings per share. equities analysts predict that AmerisourceBergen Corp. will post 6.58 EPS for the current year.
The firm also recently announced a quarterly dividend, which was paid on Monday, March 5th. Stockholders of record on Tuesday, February 20th were given a $0.38 dividend. The ex-dividend date of this dividend was Friday, February 16th. This represents a $1.52 dividend on an annualized basis and a dividend yield of 1.51%. AmerisourceBergen’s payout ratio is presently 32.76%.
AmerisourceBergen Corporation is a pharmaceutical sourcing and distribution services company. The Company’s segments include Pharmaceutical Distribution and Other. The Company provides services to healthcare providers, and pharmaceutical and biotech manufacturers. As of June 30, 2016, the Pharmaceutical Distribution segment consists of two operating segments, including the operations of AmerisourceBergen Drug Corporation (ABDC) and AmerisourceBergen Specialty Group (ABSG), which distributes specialty drugs to their customers.
Want to see what other hedge funds are holding ABC? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for AmerisourceBergen Corp. (NYSE:ABC).
Receive News & Ratings for AmerisourceBergen Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for AmerisourceBergen and related companies with MarketBeat.com's FREE daily email newsletter.